Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species

Journal of Virology
Christian JoglerOliver Wildner

Abstract

Oncolytic adenoviruses have emerged as a promising approach for the treatment of tumors resistant to other treatment modalities. However, preclinical safety studies are hampered by the lack of a permissive nonhuman host. Screening of a panel of primary cell cultures from seven different animal species revealed that porcine cells support productive replication of human adenovirus type 5 (Ad5) nearly as efficiently as human A549 cells, while release of infectious virus by cells from other animal species tested was diminished by several orders of magnitude. Restriction of productive Ad5 replication in rodent and rabbit cells seems to act primarily at a postentry step. Replication efficiency of adenoviral vectors harboring different E1 deletions or mutations in porcine cells was similar to that in A549 cells. Side-by-side comparison of the viral load kinetics in blood of swine and mice injected with Ad5 or a replication-deficient adenoviral vector failed to provide clear evidence for virus replication in mice. In contrast, evidence suggests that adenovirus replication occurs in swine, since adenoviral late gene expression produced a 13.5-fold increase in viral load in an individual swine from day 3 to day 7 and 100-fold increase in...Continue Reading

References

Dec 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·G Akusjärvi, U Pettersson
Oct 1, 1975·The American Journal of Medicine·R L MyerowitzJ C Hierholzer
Jan 15, 1976·International Journal of Cancer. Journal International Du Cancer·M LieberG Todaro
Jul 1, 1978·The Journal of General Virology·S J DuncanH N Willcox
Nov 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·S KvistP A Peterson
Jul 1, 1977·The Journal of General Virology·F L GrahamR Nairn
Jul 1, 1992·Clinical Microbiology Reviews·J C Hierholzer
Jan 1, 1992·The Journal of Infectious Diseases·M G MichaelsT E Starzl
Jan 1, 1992·The Journal of Pediatrics·B CamesE M Sokal
Mar 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·H S GinsbergG A Prince
Jun 1, 1990·The Pediatric Infectious Disease Journal·D JannerP H Azimi
Aug 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·H S GinsbergG A Prince
Oct 1, 1990·The Pediatric Infectious Disease Journal·L R KrilovL G Rubin
Dec 1, 1989·Virus Research·G E BlairM E Zajdel
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·H S GinsbergG A Prince
Aug 1, 1981·Journal of Virology·A W BraithwaiteA J Bellett
Jun 1, 1995·Molecular Biotechnology·F L Graham, L Prevec
Apr 1, 1994·The Journal of Infectious Diseases·P FlomenbergN Bunin
Jan 1, 1993·Journal of Virology·G A PrinceH S Ginsberg
Aug 1, 1995·The Pediatric Infectious Disease Journal·M ArolaT T Salmi
May 2, 1996·The New England Journal of Medicine·J M Wilson
Nov 1, 1996·Journal of Virology·N MitterederB C Trapnell
Jan 1, 1997·Journal of the National Cancer Institute·J A Roth, R J Cristiano
Feb 23, 2000·Journal of Virology·I GanlyA Balmain
Mar 17, 1997·The American Journal of Medicine·D R Carrigan
Aug 10, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·J C Morris, O Wildner
Oct 20, 2000·The Journal of General Virology·R AlemanyD T Curiel
Feb 24, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J NemunaitisD Kirn
Jun 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A Yver
Jan 10, 2002·Human Gene Therapy·Jay N LozierRichard A Morgan
Feb 25, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Akseli HemminkiDavid T Curiel
Aug 30, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Gunnel HalldénDavid Kirn

❮ Previous
Next ❯

Citations

May 21, 2008·Proceedings of the National Academy of Sciences of the United States of America·Karoly TothWilliam S M Wold
Jul 31, 2007·Human Gene Therapy·Sergia BortolanzaRuben Hernandez-Alcoceba
Dec 9, 2010·Nucleic Acids Research·Taco G UilRob C Hoeben
May 31, 2011·Applied and Environmental Microbiology·Samuel D SibleyJoel A Pedersen
Jun 8, 2011·The Journal of Clinical Investigation·Norman WollerFlorian Kühnel
Feb 19, 2010·Virology Journal·Marie-Noëlle TakahashiKatherine E Owen
Feb 12, 2014·Human Gene Therapy·Rodinde HendrickxUrs F Greber
Feb 7, 2016·Research in Veterinary Science·Dong-sheng GaoJun Zhao
Apr 28, 2009·Advanced Drug Delivery Reviews·Dominik E Dorer, Dirk M Nettelbeck
Dec 25, 2007·Veterinary Microbiology·Louise LohseJens Nielsen
Aug 21, 2009·Veterinary and Comparative Oncology·M ArendtI M Morgan
Sep 28, 2007·Traffic·Olga L MiakotinaRama K Mallampalli
Apr 7, 2010·Journal of Viral Hepatitis·M John von FreyendU Protzer
Jan 1, 2014·International Journal of Cancer. Journal International Du Cancer·Simona BramanteAkseli Hemminki
Jul 27, 2015·Drug Discovery Today·Pablo Martínez-AguadoJavier Sánchez-Céspedes
Dec 18, 2008·The Journal of General Virology·W C Russell
Jan 19, 2016·Mathematical Biosciences and Engineering : MBE·Joanna R WaresPeter S Kim
May 28, 2013·Vaccine·Cailin DealGary Ketner
Sep 21, 2013·Ultrastructural Pathology·Olaf AnhennDirk Theegarten
May 8, 2015·Oncoimmunology·Heather GibsonWei-Zen Wei
May 15, 2015·Mathematical Biosciences and Engineering : MBE·Peter S KimJoanna R Wares
Jan 15, 2008·Virology·Nadine GriescheBarbara Biere
Feb 13, 2007·Virology·Holger A Lindner
Sep 14, 2010·Journal of the American Chemical Society·Partha Sarathi BanerjeeIsaac Carrico
Sep 7, 2016·Journal of Virological Methods·Jennifer L CashdollarAnn C Grimm
Jan 23, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Eduardo LabordaRamon Alemany
Aug 24, 2017·Viruses·Daniel N SantiagoHeiko Enderling
Jan 12, 2010·Current Opinion in Organ Transplantation·Anne-Laure Millard, Nicolas J Mueller
Nov 27, 2019·FEBS Letters·Svetlana AtashevaDmitry M Shayakhmetov
Jun 3, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Patrick J CalhounJames W Smyth
Apr 6, 2017·Scientific Reports·Mirja RamkeJames Chodosh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.